"Through the collaboration with Coremine Vitae, many of the Brain Tumor Association's members have gained access to their own Coremine Vitae report as a supplement to their regular treatment.
Through the report, they have received information about relevant treatments that are adapted to their personal medical profile, based on their genetic profile and disease. The report has thus helped patients to make better decisions about treatment and opportunities for participation in clinical trials by facilitating better co-choice."
Rolf J. Ledal
Secretary General of the Brain Tumour Society